Entreprise · 31/07/19971 min de lecture
Tolerances for Residues of New Animal Drugs in Food; Apramycin
Traduction automatique locale · Langue originale de la source
Résumé
The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect approval of two supplemental new animal drug applications (NADA's) filed by Elanco Animal Health, A Division of Eli Lilly & Co. The supplemental NADA's provide for revised tolerances for total residues of apramycin (i.e., the safe concentration) in edible swine tissues.